Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-19

Clinical Trial Update: Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study is evaluating Nephropathy Formula No. 1 in adults with chronic kidney disease due to chronic renal insufficiency. The trial status indica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nephropathy Formula No. 1

Snippet

Sponsor: Liu Zhanghong | Conditions: Renal Insufficiency, Chronic | EARLY_Phase 1 | Status: NOT_YET_RECRUITING